• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能受损患者的万古霉素治疗:剂量列线图

Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

作者信息

Moellering R C, Krogstad D J, Greenblatt D J

出版信息

Ann Intern Med. 1981 Mar;94(3):343-6. doi: 10.7326/0003-4819-94-3-343.

DOI:10.7326/0003-4819-94-3-343
PMID:6101256
Abstract

The relation between vancomycin clearance and renal function was studied in 22 patients with various degrees of renal functional impairment and in four normal volunteers. Clearance of vancomycin and creatinine were highly correlated (r = 0.92) among 17 persons not on dialysis. In five dialysis patients vancomycin clearance averaged 0.086 mL/min . kg of body weight (+/- SEM = 0.025). These relations enabled us to construct a nomogram for vancomycin dosage adjustment (based on a mean steady-state serum vancomycin concentration of 15 micrograms/mL) in patients with various degrees of renal functional impairment.

摘要

对22例不同程度肾功能损害患者及4名正常志愿者进行了万古霉素清除率与肾功能关系的研究。在17名未接受透析的患者中,万古霉素清除率与肌酐清除率高度相关(r = 0.92)。5例透析患者的万古霉素清除率平均为0.086 mL/分钟·千克体重(±标准误 = 0.025)。这些关系使我们能够为不同程度肾功能损害患者构建万古霉素剂量调整列线图(基于平均稳态血清万古霉素浓度为15微克/毫升)。

相似文献

1
Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.肾功能受损患者的万古霉素治疗:剂量列线图
Ann Intern Med. 1981 Mar;94(3):343-6. doi: 10.7326/0003-4819-94-3-343.
2
Pharmacokinetics of vancomycin in patients with various degrees of renal function.不同肾功能程度患者中万古霉素的药代动力学
Antimicrob Agents Chemother. 1984 Apr;25(4):433-7. doi: 10.1128/AAC.25.4.433.
3
A simplified dosing method for initiating vancomycin therapy.一种用于启动万古霉素治疗的简化给药方法。
Pharmacotherapy. 1985 Nov-Dec;5(6):340-4. doi: 10.1002/j.1875-9114.1985.tb03441.x.
4
Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.万古霉素在不同肾功能患者中的应用,尤其是那些肾脏清除率增加的患者。
Pharm Biol. 2016 Dec;54(12):2802-2806. doi: 10.1080/13880209.2016.1183684. Epub 2016 Jun 1.
5
Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function.万古霉素在正常受试者及肾功能减退患者中的药代动力学。
Rev Infect Dis. 1981 Nov-Dec;3 suppl:S230-5.
6
Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.一项开放标签、单剂量药代动力学研究的数据显示,在肾功能不同的患者中,使用加巴喷丁恩卡他伯尔缓释片后,加巴喷丁的临床药代动力学。
Clin Ther. 2012 Jan;34(1):201-13. doi: 10.1016/j.clinthera.2011.12.004. Epub 2011 Dec 28.
7
Vancomycin dosing chart for use in patients with renal impairment.
Am J Kidney Dis. 1988 Jan;11(1):15-9. doi: 10.1016/s0272-6386(88)80168-9.
8
Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.环丙沙星在健康志愿者和肾功能受损患者中的药代动力学。
J Antimicrob Chemother. 1986 Nov;18 Suppl D:83-7. doi: 10.1093/jac/18.supplement_d.83.
9
Application of vancomycin in patients with augmented renal clearance.万古霉素在肾清除增强患者中的应用。
Eur J Hosp Pharm. 2020 Sep;27(5):276-279. doi: 10.1136/ejhpharm-2018-001781. Epub 2019 Jan 9.
10
Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function.头孢唑肟在不同程度肾功能受试者中的药代动力学。
Antimicrob Agents Chemother. 1983 Aug;24(2):151-5. doi: 10.1128/AAC.24.2.151.

引用本文的文献

1
Optimizing Initial Vancomycin Dosing in Hospitalized Patients Using Machine Learning Approach for Enhanced Therapeutic Outcomes: Algorithm Development and Validation Study.使用机器学习方法优化住院患者初始万古霉素剂量以提高治疗效果:算法开发与验证研究
J Med Internet Res. 2025 Mar 31;27:e63983. doi: 10.2196/63983.
2
Prediction of vancomycin initial dosage using artificial intelligence models applying ensemble strategy.应用集成策略的人工智能模型预测万古霉素初始剂量。
BMC Bioinformatics. 2023 Mar 22;22(Suppl 5):637. doi: 10.1186/s12859-022-05117-8.
3
Vancomycin Resistance in and .
[具体研究对象]中的万古霉素耐药性 以及[具体研究对象]。 你提供的原文信息不完整,我只能按照要求进行这样的翻译。请补充完整原文以便我能给出更准确的译文。
Microorganisms. 2022 Dec 21;11(1):24. doi: 10.3390/microorganisms11010024.
4
Optimizing Vancomycin Dosing in Chronic Kidney Disease by Deriving and Implementing a Web-Based Tool Using a Population Pharmacokinetics Analysis.
Front Pharmacol. 2019 Jun 11;10:641. doi: 10.3389/fphar.2019.00641. eCollection 2019.
5
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK Observations.应用万古霉素 PBPK 模型于特殊人群以阐明基于病例的临床 PK 观察。
CPT Pharmacometrics Syst Pharmacol. 2018 Apr;7(4):237-250. doi: 10.1002/psp4.12279. Epub 2018 Feb 15.
6
Full hydrodynamic reversibility of the weak dimerization of vancomycin and elucidation of its interaction with VanS monomers at clinical concentration.万古霉素弱二聚化的完全流体动力学可逆性及其与临床浓度下 VanS 单体相互作用的阐明。
Sci Rep. 2017 Oct 5;7(1):12697. doi: 10.1038/s41598-017-12620-z.
7
Relationships of Vancomycin Pharmacokinetics to Body Size and Composition Using a Novel Pharmacomorphomic Approach Based on Medical Imaging.基于医学影像的新型药效形态学方法研究万古霉素药代动力学与人体大小和组成的关系。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01402-17. Print 2017 Nov.
8
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.老年患者静脉注射万古霉素的给药:关注临床问题与实际应用
Drugs Aging. 2016 Dec;33(12):845-854. doi: 10.1007/s40266-016-0420-z.
9
Evaluation of the Safety of a Vancomycin Nomogram Used to Achieve Target Trough Concentrations.用于达到目标谷浓度的万古霉素剂量图表的安全性评估。
Hosp Pharm. 2015 Nov;50(10):900-910. doi: 10.1310/hpj5010-900. Epub 2015 Nov 19.
10
Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.针对不同人群高血清谷浓度的万古霉素给药剂量表:利弊
Eur J Clin Pharmacol. 2016 Jul;72(7):777-88. doi: 10.1007/s00228-016-2063-8. Epub 2016 Apr 27.